Tin tức & Cập nhật

Universal DAA access tied to reduced HCV prevalence in PLHIV

20 Aug 2021 bởi

Universal access to direct-acting antivirals (DAAs) may have led to the low prevalence of hepatitis C viraemia among people living with HIV (PLHIV) in The Netherlands, according to a study presented at IAS 2021.

Universal DAA access tied to reduced HCV prevalence in PLHIV

20 Aug 2021

Omega-3-enriched diet cuts headache days

20 Aug 2021 bởi

Consuming a diet enriched with the EPA and DHA* omega-3 fatty acids leads to less frequent and milder headache in patients with migraine, according to a double-blind, randomized study.

Omega-3-enriched diet cuts headache days

20 Aug 2021

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

20 Aug 2021

Later-line chemotherapy does not seem to improve oral intake in patients with advanced gastric cancer (AGC), which is why careful adaptation of regimens is necessary for those at risk for impaired oral intake, suggests a recent study.

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

20 Aug 2021

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021 bởi

In individuals with neurogenic detrusor overactivity incontinence (NDOI) who were regularly undergoing clean intermittent catheterization, significant reductions of urinary incontinence episodes were seen following treatment with abobotulinumtoxinA (aboBoNT-A), according to a pooled analysis of two CONTENT studies presented at EAU 2021.

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021 bởi

Tenofovir alafenamide (TAF), administered during the second or third trimester of pregnancy, may prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV) infection, according to two studies presented as posters at ILC 2021.

Tenofovir alafenamide may prevent HBV mother-to-child transmission

19 Aug 2021

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

19 Aug 2021 bởi

Treatment with olokizumab yields significant improvements in signs and symptoms of rheumatoid arthritis (RA), particularly among patients with active disease despite receipt of an adequate dose of methotrexate, according to the results of the phase III CREDO 1 trial.

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

19 Aug 2021

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021 bởi

In a systematic review and meta-analysis of randomized controlled trials (RCTs) presented at EAU 2021, the use of botulinum toxin (BTX) type A in individuals with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (iOAB) led to a reduction in incontinence episodes.

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

18 Aug 2021

Use of oral ondansetron in the treatment of children with gastroenteritis who seek emergency department (ED) care works to reduce index ED visit intravenous (IV) fluid administration, a study has found. The drug has null effects on other outcomes.

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

18 Aug 2021

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

18 Aug 2021

Switching from once-daily to once-weekly dipeptidyl peptidase 4 (DPP-4) inhibitors works to maintain fasting plasma glucose and time in range in patients with type 2 diabetes mellitus, a study has shown.

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

18 Aug 2021

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

New drug applications approved by US FDA as of 01-15 August 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Universal DAA access tied to reduced HCV prevalence in PLHIV

Universal DAA access tied to reduced HCV prevalence in PLHIV

Omega-3-enriched diet cuts headache days

Omega-3-enriched diet cuts headache days

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

Oral intake of advanced gastric cancer patients worsens in later-line chemotherapy

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

Tenofovir alafenamide may prevent HBV mother-to-child transmission

Tenofovir alafenamide may prevent HBV mother-to-child transmission

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

CREDO 1: Novel biologic for rheumatoid arthritis hits mark

Botulinum toxin type A may reduce incontinence episodes

Botulinum toxin type A may reduce incontinence episodes

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

Ondansetron reduces IV fluid administration in paediatric gastroenteritis

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

Once-weekly DPP-4 inhibitor delivers in type 2 diabetes

Original New Drug Application Approvals by US FDA (01-15 August 2021)

Original New Drug Application Approvals by US FDA (01-15 August 2021)